🔗 Share this article

As the United States proceeds with historic adjustments to its vaccination recommendations, a particular individual has surfaced unexpectedly: Dr. Tracy Beth Høeg, an American of Danish descent sports medicine doctor and public health researcher who rose to prominence by expressing skepticism about COVID-19 shots throughout the pandemic and has focused upon alleged deaths after COVID-19 vaccination in her recent time at the FDA.

Planned Shifts to Pediatric Vaccine Program

Agency leaders were set to reveal radical changes to the pediatric vaccine schedule earlier this month, synchronizing the US with Denmark’s vaccine program, sources say – a major change that would put the US out of alignment with much of the global community with little proof for benefit. The announcement has been delayed until the next year.

Rather than the director of the vaccine center, Tracy Beth Høeg is listed to present at the meeting. She was just designated interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to lead the center this calendar year.

Consolidating Power at the FDA

This interim role might represent a tighter collaboration between the pharmaceutical and vaccine divisions as Høeg and Prasad consolidate power at the FDA – and it signals a increased emphasis upon reevaluating previously authorized vaccines at the FDA.

Høeg has frequently advocated for halting some pediatric immunization guidelines in the US to become more similar to Denmark, a country with nationalized medicine and a number of inhabitants approximately the population of the state of Wisconsin.

To date statements, she has kept her attention on immunizations – usually the responsibility of Prasad, director of the FDA’s CBER – rather than medication approval.

Doubts Over Background

Høeg has no obvious background in medication creation, oversight or management, which has been standard for past heads of the biologics center. She has served at the FDA as a senior adviser to the agency head and the vaccine center since spring.

“She appears not to have any of the qualifications” for leading the CDER, stated a neurologist and psychiatrist. “She lacks experience running a scientific study. She lacks experience in leading a sizeable institution. She is not an expert in pharmaceutical oversight.”

Past directors of the center would “be deeply familiar with regulatory frameworks and the research of medication creation”, noted a former acting FDA commissioner. “Objectively, she lacks the kind of background that previous people who headed CBER have had.”

The drug center has an enormous workload at the FDA, Woodcock emphasized.

“Many people just focuses on the new drug program, but the generic drug division approves thousands of generic medications. There’s a biosimilars program, OTC medication office and more, and each of these need to be managed,” Dr. Woodcock noted. “The responsibility you neglect, that’s the thing that I always told people is going to bite you.”

There is also, a significant leadership component to the job, which supervises more than 5,000 employees. “It is a massive leadership role, if you perform it correctly,” she said.

Agency Reaction and Controversial Policies

In response to inquiries about Dr. Høeg's credentials and whether this assignment signifies increased cooperation among FDA leaders on immunizations, a spokesperson stated that the “concerns are based on flawed presumptions”.

“Her resume aligns with the duties of her position,” the representative said, citing the months Dr. Høeg spent guiding the FDA commissioner on “drug safety and approval science, including computational safety modeling and vaccine surveillance”.

In her interim role, Dr. Høeg assumes responsibility for the commissioner’s recently launched priority voucher program, a disputed expedited therapy clearance system that allegedly troubled her predecessors. “By what process are these medications being selected for this expedited pathway? Who makes the choices?” Howard questioned. “There is a lot of secrecy happening at the regulatory body right now.”

Overall, he stated, “the agency appears to be shifting towards less stringent regulations of pharmaceuticals, with the exception of vaccines.”

Established History on Vaccines

Concerning immunizations, Dr. Høeg has a more documented, if troubling, history, Howard have noted. She published a research paper using unconfirmed volunteer-provided data to assess the frequency of heart inflammation after Covid immunization. She counseled the Florida top health official Dr. Joseph Ladapo, who was said to have modified findings to suggest COVID-19 vaccines are pose a greater threat than they are.

Among her “policy goals” for the new administration encompassed revising guidelines for new vaccines and discontinuing “optional” vaccines, she remarked following the vote on a online show. At the FDA, Høeg has allegedly floated the idea of barring teenage boys from receiving Covid vaccines.

“She is an thorough true believer who begins with her beliefs and reverse-engineers to retrofit the science in a very disingenuous, fraudulent way,” Dr. Howard stated.

Gaining Influence and a “Campaign of Retribution”

Høeg joined other skeptics, {like|